Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GENTAMICIN Cause Interstitial lung disease? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Interstitial lung disease have been filed in association with GENTAMICIN (Gentamicin). This represents 0.4% of all adverse event reports for GENTAMICIN.

29
Reports of Interstitial lung disease with GENTAMICIN
0.4%
of all GENTAMICIN reports
22
Deaths
28
Hospitalizations

How Dangerous Is Interstitial lung disease From GENTAMICIN?

Of the 29 reports, 22 (75.9%) resulted in death, 28 (96.6%) required hospitalization, and 23 (79.3%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GENTAMICIN. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does GENTAMICIN Cause?

Acute kidney injury (1,026) Drug ineffective (824) Off label use (363) Maternal exposure during pregnancy (360) Foetal exposure during pregnancy (324) Premature baby (315) Product use in unapproved indication (313) Pyrexia (302) Premature delivery (283) Condition aggravated (252)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which GENTAMICIN Alternatives Have Lower Interstitial lung disease Risk?

GENTAMICIN vs GEODON GENTAMICIN vs GIANVI GENTAMICIN vs GILENYA GENTAMICIN vs GILOTRIF GENTAMICIN vs GILTERITINIB

Related Pages

GENTAMICIN Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease GENTAMICIN Demographics